Improving Breast Cancer Grade Prediction with Multiparametric MRI Created Using Optimized Synthetic Correlated Diffusion Imaging
Chi-en Amy Tai, Alexander Wong
TL;DR
This work targets noninvasive breast cancer grade prediction, addressing the limitations of biopsy-based grading. It optimizes synthetic correlated diffusion imaging signals, CDI$^s$, via Nelder–Mead to maximize AUC for tumor delineation and fuses the optimized CDI$^s$ with diffusion-weighted imaging to form a multiparametric MRI. An end-to-end deep radiomic pipeline using a MONAI 34-layer volumetric residual CNN processes 224×224×25 brain? volumes (per patient) to predict grades, evaluated with leave-one-out cross-validation. Results show a LOOCV accuracy of 95.79% with optimized CDI$^s$, surpassing 87.70% for the unoptimized approach and achieving high sensitivity and specificity, indicating a promising noninvasive approach for breast cancer grading and highlighting the benefit of domain-specific CDI optimization.
Abstract
Breast cancer was diagnosed for over 7.8 million women between 2015 to 2020. Grading plays a vital role in breast cancer treatment planning. However, the current tumor grading method involves extracting tissue from patients, leading to stress, discomfort, and high medical costs. A recent paper leveraging volumetric deep radiomic features from synthetic correlated diffusion imaging (CDI$^s$) for breast cancer grade prediction showed immense promise for noninvasive methods for grading. Motivated by the impact of CDI$^s$ optimization for prostate cancer delineation, this paper examines using optimized CDI$^s$ to improve breast cancer grade prediction. We fuse the optimized CDI$^s$ signal with diffusion-weighted imaging (DWI) to create a multiparametric MRI for each patient. Using a larger patient cohort and training across all the layers of a pretrained MONAI model, we achieve a leave-one-out cross-validation accuracy of 95.79%, over 8% higher compared to that previously reported.
